Memorial Sloan-Kettering epidemiologist Peter Bach comments on new research that found that surgery is surprisingly common in older people during the last year, month, and even week of life.
Why is breast cancer in young women so much harder to treat? Memorial Sloan-Kettering Chief of the Breast Cancer Services, Clifford Hudis, addresses the question in this issue of Self.
People with cancer from around the globe benefit "from receiving care at the very place where physicians and scientists pioneer new treatments, refine standard approaches, and use sophisticated combinations of therapy to increase the cure rate of cancer,” Vice President for International Programs and cancer surgeon Murray Brennan told Medical Tourism Magazine.
Breast surgeon Alexandra Heerdt is interviewed in this special about treatment options and protocols that are improving the odds of surviving breast cancer.
Memorial Sloan-Kettering’s Vice President of Development, Richard Naum, spoke about this year’s Wall Street Decathlon to benefit Memorial Sloan-Kettering.
Executive Director of Memorial Sloan-Kettering’s Regional Care Network Victor Ribaudo and Executive Vice President of Memorial Sloan-Kettering John Gunn spoke about plans to open a regional cancer treatment center in Harrison, NY.
Gynecologic oncologist Carol Brown, MD, was quoted in USA Today and featured on NY1 to discuss research published in The Lancet Oncology that found IUDs may prevent cervical cancer.
Gynecologic oncologist Carol Brown, MD, was featured as a guest on The Dr. Oz Show to offer her clinical expertise on the early warning signs of ovarian cancer.
Biostatistician Camelia Sima, MD, MS, discussed questions being raised about the over-testing of older patients and the growing skepticism about the widespread practice of routine screening for cancer and other ailments of people in their 70s, 80s, and 90s.
Medical oncologist Andrew Seidman, MD, discussed research presented at the 2011 Breast Cancer Symposium that underscores the importance of mammograms and breast self-exams for the detection of breast cancer.
Newark Fire Department Captain and 9/11 first responder Mike Sorace, who has battled throat cancer, visited radiation oncologist Karen Schupak, MD, at Memorial Sloan-Kettering Basking Ridge for a follow-up visit after a course of radiation treatments.
Thoracic oncologist Mark Kris, MD, was interviewed about the FDA approval of crizotinib (Xalkori®), a drug that shrinks tumors in lung-cancer patients with a rare genetic abnormality.
Paul Glare, MD, Chief of the Pain and Palliative Care Service, was interviewed about an editorial he wrote to accompany a study published in the British Medical Journal that found a new scoring system might be able to tell patients in the final stages of cancer how much time they have left so they can prepare for their passing. Dr. Glare was also quoted in the Huffington Post.
